Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

Journal of Experimental Medicine

Volumn 188, Issue 1, 1998, Pages 83-91

  Chun, Tae Wook ^a   Engel, Delphine ^a   Mizell, Stephanie B ^a   Ehler, Linda A ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antiretroviral therapy; Cytokines; HIV 1; Latency; Resting CD4+ T cells

Indexed keywords

CD4 ANTIGEN; CYTOKINE; DIDANOSINE; INDINAVIR; INTERLEUKIN 2; INTERLEUKIN 6; LAMIVUDINE; RITONAVIR; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LATENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; HIV-1; HLA-DR ANTIGENS; HUMANS; INFECTION; RECEPTORS, INTERLEUKIN-2; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0032490570     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.1.83     Document Type: Article

References (47)

1. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
2. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 262: 1011-1018.
3. Poli, G., and A.S. Fauci. 1993. Cytokine modulation of HIV expression. Semin. Immunol. 5:165-73.
4. Poli, G., and A.S. Fauci. 1995. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In Human Cytokines: Their Role in Disease and Therapy. B.B. Aggarwal and R.K. Puri, editors. Blackwell Science, Cambridge, MA. 421-449.
5. Fauci, A.S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:529-534.
6. Kinter, A.L., G. Poli, L. Fox, E. Hardy, and A.S. Fauci. 1995. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J. Immunol. 154:2448-2459.
7. Folks, T., D.M. Powell, M.M. Lightfoote, S. Benn, M.A. Martin, and A.S. Fauci. 1986. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science. 231:600-602.
8. Folks, T., J. Justement, A. Kinter, C. Dinarella, and A.S. Fauci. 1987. Cytokine induced expression of HIV-1 in a chronically-infected promocyte cell line. Science: 238:800-801.
9. Poli, G., and A.S. Fauci. 1996. Cytokine cascades in HIV infection. In Immunology of HIV Infection. S, Gupta, editor. Plenum Press, New York. 285-301.
10. Osborn, L., S. Kunkel, and G.J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA. 86:2336-2340.
11. Kobayashi, N., Y. Hamamoto, Y. Koyanagi, I.S. Chen, and N. Yamamoto. 1989. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. Biochem. Biophys. Res. Commun. 165:715-721.
12. Poli, G., P. Bressler, A. Kinter, E. Duh, W.C. Timmer, A. Rabson, J.S. Justement, S. Stanley, and A.S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151-158.
13. Poli, G., A.L. Kinter, and A.S. Fauci. 1994. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:108-112.
14. Belec, L., D. Meillet, A. Hernvann, G. Gresenguet, and R. Gherardi. 1994. Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states. Clin. Diagn. Lab. Immunol. 1:117-120.
15. Roux-Lombard, P., C. Modoux, A. Cruchaud, and J.M. Dayer. 1989. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin. Immunol. Immunopathol. 50:374-384.
16. Hober, D., A. Haque, P. Wattre, G. Beaucaire, Y. Mouton, and A. Capron. 1989. Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78:329-333.
17. Navikas, V., J. Link, G. Persson, T. Olsson, B. Hojeberg, A. Ljungdahl, H. Link, and B. Wahren. 1995. Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9:484-489.
18. Trentin, L., S. Garbisa, R. Zambello, G. Agostini, C. Caenazzo, C. Di Francesco, A. Cipriani, E. Francavilla, and G. Semenzato. 1992. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J. Infect. Dis. 166:731-737.
19. Ito, M., M. Baba, S. Mori, K. Hirabayashi, A. Sato, S. Shigeta, and E. De Clercq. 1990. Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro. Biochem. Biophys. Res. Commun. 166:1095-1101.
20. Le Naour, R., H. Raoul, A. Mabondzo, Y. Henin, A. Bousseau, and D. Dormont. 1994. Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. Res. Virol. 145:199-207.
21. Granowitz, E.V., B.M. Saget, M.Z. Wang, C.A. Dinarello, and P.R. Skolnik. 1995. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol. Med. 1:667-677.
22. Goletti, D., A.L. Kinter, E.C. Hardy, G. Poli, and A.S. Fauci. 1996. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J. Immunol. 156: 3501-3508.
23. Herbein, G., L.J. Montaner, and S. Gordon. 1996. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J. Virol. 70:7388-7397.
24. Chun, T.W., L. Stuyver, S.B. Mizell, L.A. Ehler, J.A. Mican, M. Baseler, A.L. Lloyd, M.A. Nowak, and A.S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 94: 13193-13197.
25. Finzi, D., M. Hermankova, T. Pierson, L.M. Carruth, C. Buck, R.E. Chaisson, T.C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1295-300.
26. Wong, J.K., M. Hezareh, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, C.A. Spina, and D.D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science: 278:1291-1295.
27. Chun, T.W., L. Carruth, D. Finzi, X. Shen, J.A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T.C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:183-188.
28. Pantaleo, G., and A.S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
29. Stanley, S., M.A. Ostrowski, J.S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D.J. Schwartzentruber, C.H. Fox, and A.S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334:1222-1230.
30. Staprans, S.I., B.L. Hamilton, S.E. Follansbee, T. Elbeik, P. Barbosa, R.M. Grant, and M.B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
31. O'Brien, W.A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H.J. Wang, J. Park, C. Yeramian, S.H. Mao, and J.A. Zack. 1995. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 86:1082-1089.
32. Ostrowski, M.A., S.K. Stanley, J.S. Justement, K. Gantt, D. Gioletti, and A.S. Fauci. 1997. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. AIDS Res. Hum. Retroviruses. 13:473-480.
33. de Jong, M.D., R.J. de Boer, F. de Wolf, N.A. Foudraine, C.A. Boucher, J. Goudsmit, and J.M. Lange. 1997. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS (London). 11:F79-84.
34. Parrillo, J.E., and A.S. Fauci. 1979. Mechanisms of glucocorticoid action on immune processes. Annu. Rev. Pharmacol. Toxicol. 19:179-201.
35. Zimmerman, G.A., S.M. Prescott, and T.M. McIntyre. 1992. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol. Today. 13:93-100.
36. Sternberg, E.M., G.P. Chrousos, R.L. Wilder, and P.W. Gold. 1992. The stress response and the regulation of inflammatory disease. Ann. Intern. Med. 117:854-866.
37. Bressler, P., G. Poli, J.S. Justement, P. Biswas, and A.S. Fauci. 1993. Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. AIDS Res. Hum. Retroviruses. 9:547-551.
38. Biswas, P., G. Poli, J.M. Orenstein, and A.S. Fauci. 1994. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? J. Virol. 68:2598-2604.
39. Schleimer, R.P. 1993. An overview of glucocorticoid antiinflammatory actions. Eur. J. Clin. Pharmacol. 45 (Suppl. 1):S3-7.
40. Almawi, W.Y., H.N. Beyhum, A.A. Rahme, and M.J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukocyte Biol. 60:563-572.
41. Schwiebert, L.M., L.A. Beck, C. Stellato, C.A. Bickel, B.S. Bochner, R.P. Schleimer, and L.A. Schwiebert. 1996. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 97:143-152.
42. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin, Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:283-286.
43. Graziosi, C., G. Pantaleo, K.R. Gantt, J.P. Fortin, J.F. Demarest, O.J. Cohen, R.P. Sekaly, and A.S. Fauci. 1994. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals, Science. 265:248-252.
44. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:123-126.
45. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117-122.
46. Perelson, A.S., A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell lite-span, and viral generation time. Science. 271:1582-1586.
47. Myers, L.E., L.J. McQuay, and F.B. Hollinger. 1994. Dilution assay statistics. J. Clin. Microbiol. 32:732-739.